FY2025 · ended Dec 31, 2025 · Revenue $5.10B, +6.5% YoY · Filed Feb 18, 2026
Bausch & Lomb Corp (BLCO) files with the SEC under industry code 3851, Ophthalmic Goods. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $5.1 billion and a net loss of $360.0 million. Free cash flow was -$66.0 million. As of Sep 30, 2026 it held $513.0 million in cash and investments and $5.0 billion in total debt.
Revenue (TTM)
$5.42B
+8.9% vs year-ago TTM
Net income (TTM)
$-111.00M
+63.6% vs year-ago TTM
Operating cash flow (TTM)
$554.00M
+227.8% vs year-ago TTM
Free cash flow (TTM)
$252.00M
+228.6% vs year-ago TTM
EPS (TTM)
$-0.31
+63.9% vs year-ago TTM
Dividend per share
None
Shares outstanding
354.32M
+0.5% vs prior year
Net cash
$-4.50B
as of Sep 30, 2026
Operating margin
7.1%
FY 2026
Company profile
- Industry
- Ophthalmic Goods (SIC 3851)
- Listed as
- BLCO (NYSE)
- Fiscal year ends
- December 31
- Headquarters
- Vaughan, Ontario, Canada
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1860742
Other Ophthalmic Goods companies
- Alcon Inc ALC
- Cooper Companies, Inc. COO
- Warby Parker Inc. WRBY
- National Vision Holdings, Inc. EYE
- Staar Surgical Co STAA
- RxSight, Inc. RXST
- Innovative Eyewear Inc LUCY
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| Revenue | $5.1B | $4.8B | $4.1B | $3.8B |
| Operating income | $113.0M | $162.0M | $130.0M | $207.0M |
| Net income | -$360.0M | -$317.0M | -$260.0M | $6.0M |
| Diluted EPS | -$1.02 | -$0.90 | -$0.74 | $0.02 |
| Operating cash flow | $283.0M | $232.0M | -$17.0M | $345.0M |
| Free cash flow | -$66.0M | -$59.0M | -$198.0M | $170.0M |
| Total assets | $14.0B | $13.5B | $13.4B | $11.1B |
| Total liabilities | $7.5B | $6.9B | $6.5B | $4.0B |
| Stockholders' equity | $6.4B | $6.5B | $6.8B | $7.0B |
| Cash and investments | $383.0M | $305.0M | $331.0M | $354.0M |
| Total debt | $5.2B | $4.9B | $4.7B | $2.6B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 28, 2026 | Oct 28, 2026 |
| 10-Q | Quarterly report | Oct 28, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 13, 2026 | Oct 11, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Aug 12, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Aug 6, 2026 | Aug 5, 2026 |
All 371 Bausch & Lomb Corp SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.